Catalytic antibody 14D9 catalyzes the enantioselective protonation of prochiral enol ethers with high enantioselectivity (>99% ee) and a practical turnover (kcat ‫؍‬ 0.4 s ؊1 ), allowing for preparative scale applications. This antibody represents one of the rare examples of catalytic antibodies promoting acid-catalyzed processes. Antibody 14D9 was cloned and expressed as a chimeric Fab fragment in Escherichia coli. Crystal structures of Fab 14D9 as apo form and of its close analog 19C9 in complex with the transition state analog were determined at 2.8-Å resolution. A series of site-directed mutagenesis experiments was carried out to probe the role of individual active-site amino acids. Proton transfer to carbon is catalyzed by a hydrogen bond network formed by the side chains of Asp H101 and Tyr L36 with a water molecule serving as a relay. The intermediate oxocarbonium ion formed during the protonation step is trapped by the same water molecule, resulting in an overall syn-addition of water to the enol ether's double bond. The enantioselectivity is caused by steric crowding at the active site, mainly because of the side chain of Phe H84 . The 20-fold lower activity of 19C9 compared with 14D9 was traced down to residue Thr L46 , which forms a nonproductive hydrogen bond with the catalytic residue Asp H101 , which competes with the critical Asp H101 OTyr L36 hydrogen bond and therefore reduces catalytic efficiency. The catalytic activity of 19C9 was restored to that of 14D9 by using either site-directed mutagenesis (Thr L46 Ala) or chain shuffling. P roton transfer to or from carbon is a fundamental process in enzyme catalysis (e.g., occurring in mandelate racemase and triose phosphate isomerase) (1-3). Carbon deprotonation processes have been studied in a number of catalytic antibodies (4), including ␤-fluoride and aldol elimination (5-8), intramolecular aldol condensation (9), and the deprotonation of Kemp's benzisoxazole (10). These antibodies generally operate by means of a glutamate residue acting as a general base for proton abstraction (11). By contrast, only very few antibodies have been described to catalyze carbon protonation processes, including enol ester hydrolysis (12), and the protonation of enol ethers by antibody 14D9 (13). This antibody catalyzes the highly enantioselective (Ͼ99% ee) protonation of enol ether 2 to give ketone (S)-3 (Fig. 1) . The reaction has a practical turnover of k cat ϭ 0.4 s Ϫ1 and provided the first examples of an enantioselective gram-scale synthesis with a catalytic antibody (14). This antibody and its close relative 19C9, were obtained from an immunization against the piperidinium hapten 1b (15). Herein we report the x-ray crystal structure determinations of 14D9 in the apo form and 19C9 as a complex with hapten 1a. The antibodies were sequenced, cloned, and expressed as chimeric humanized Fab fragments in Escherichia coli. Structural information combined with site-directed mutagenesis and chain shuffling allow us to formulate the detailed reaction mechanism of carbon protonation and shed light on the origin of the enantioselectivity of these antibodies.
Catalytic antibody 14D9 catalyzes the enantioselective protonation of prochiral enol ethers with high enantioselectivity (>99% ee) and a practical turnover (kcat ‫؍‬ 0.4 s ؊1 ), allowing for preparative scale applications. This antibody represents one of the rare examples of catalytic antibodies promoting acid-catalyzed processes. Antibody 14D9 was cloned and expressed as a chimeric Fab fragment in Escherichia coli. Crystal structures of Fab 14D9 as apo form and of its close analog 19C9 in complex with the transition state analog were determined at 2.8-Å resolution. A series of site-directed mutagenesis experiments was carried out to probe the role of individual active-site amino acids. Proton transfer to carbon is catalyzed by a hydrogen bond network formed by the side chains of Asp H101 and Tyr L36 with a water molecule serving as a relay. The intermediate oxocarbonium ion formed during the protonation step is trapped by the same water molecule, resulting in an overall syn-addition of water to the enol ether's double bond. The enantioselectivity is caused by steric crowding at the active site, mainly because of the side chain of Phe H84 . The 20-fold lower activity of 19C9 compared with 14D9 was traced down to residue Thr L46 , which forms a nonproductive hydrogen bond with the catalytic residue Asp H101 , which competes with the critical Asp H101 OTyr L36 hydrogen bond and therefore reduces catalytic efficiency. The catalytic activity of 19C9 was restored to that of 14D9 by using either site-directed mutagenesis (Thr L46 Ala) or chain shuffling. P roton transfer to or from carbon is a fundamental process in enzyme catalysis (e.g., occurring in mandelate racemase and triose phosphate isomerase) (1) (2) (3) . Carbon deprotonation processes have been studied in a number of catalytic antibodies (4), including ␤-fluoride and aldol elimination (5) (6) (7) (8) , intramolecular aldol condensation (9) , and the deprotonation of Kemp's benzisoxazole (10) . These antibodies generally operate by means of a glutamate residue acting as a general base for proton abstraction (11) . By contrast, only very few antibodies have been described to catalyze carbon protonation processes, including enol ester hydrolysis (12) , and the protonation of enol ethers by antibody 14D9 (13) . This antibody catalyzes the highly enantioselective (Ͼ99% ee) protonation of enol ether 2 to give ketone (S)-3 ( Fig. 1) . The reaction has a practical turnover of k cat ϭ 0.4 s Ϫ1 and provided the first examples of an enantioselective gram-scale synthesis with a catalytic antibody (14) . This antibody and its close relative 19C9, were obtained from an immunization against the piperidinium hapten 1b (15) . Herein we report the x-ray crystal structure determinations of 14D9 in the apo form and 19C9 as a complex with hapten 1a. The antibodies were sequenced, cloned, and expressed as chimeric humanized Fab fragments in Escherichia coli. Structural information combined with site-directed mutagenesis and chain shuffling allow us to formulate the detailed reaction mechanism of carbon protonation and shed light on the origin of the enantioselectivity of these antibodies.
Materials and Methods
Affinity Chromatography Resin Preparation. A hapten affinity resin based on DEAE-cellulose was prepared in the following procedure. Ten milliliters of water-saturated DEAE-Sephacel gel (1.1-1.6 mmol amine function) was washed extensively with acetone. A solution of N-hydroxyethyl-4-iodomethyl-benzamide (1.0 g͞2.5 mmol) obtained by a standard Finkelstein procedure from the corresponding chloromethyl derivative in 5 ml of acetone was then added, and the reaction mixture was kept in the dark at 20°C for 12 h while being shaken. The unreacted ligand was then washed away with acetone extensively, and the coupled resin was resaturated with water and PBS.
Cloning of Antibody 14D9 and 19C9 Fab Gene Fragments. Total RNA was isolated from the hybridoma cell producing antibody 14D9 or 19C9 with RNeasy kit (Qiagen). The cDNA library of each antibody was constructed with the Omniscript kit (Qiagen). The Fd and chain gene fragments of 14D9 or 19C9 were amplified by PCR with degenerated primers as described (16) . Amplified PCR products were digested with XhoI-SpeI and SacI-XbaI (for the Fd and chain gene fragments, respectively) and ligated into phage display vector pcomb3H to give their corresponding combinatorial libraries (17) . The final clones, pcombIIIH-14D9 or pcombIIIH-19C9, were obtained after selection with phage display panning methods against the hapten-BSA conjugate (18) . All PCRs were carried out with Vent R polymerase (New England Biolabs) to ensure high fidelity.
19C9his allow expression of hexa-His-tagged chimeric Fab 14D9 or 19C9.
Production and Purification of Chimeric Fab Fragments for Crystallization. The TOP10 E. coli strain (Invitrogen) was transformed with pBAD-14D9 or pBAD-19C9. Preculture (1͞40 volume) was inoculated into LB medium containing 100 g/ml ampicillin at 20°C, and overexpression was performed after induction with 0.1% L-(ϩ)-arabinose at OD 600 of 1.5. One-tenth culture volume of Terrific Broth was added to implement nutrition for overexpression. After induction for 14 h, the cells were harvested and sonicated in 20 mM Tris⅐HCl, pH 7.8͞500 mM NaCl, and the supernatant of lysis was loaded into the hapten affinity resin. The chimeric Fabs 14D9 and 19C9 were eluted with 0.2 M Gly-HCl (pH 2.8) and neutralized with 1 M Tris⅐HCl (pH 9.0) Concentrations of purified antibody were determined by measuring A 280 and A 260 (21) .
Site-Directed Mutagenesis and Purification of Mutants. Site-directed mutagenesis was accomplished by a QuickChange site-directed mutagenesis protocol (Stratagene) with minor modifications and including silent restriction sites. pBAD-14D9his or pBAD19C9his are used as template. All PCRs were performed with the High Fidelity System (Roche, Gipf-Oberfrick, Switzerland). Mutant codons were generally chosen to exploit the most frequently used codon for a particular amino acid among highly expressed genes in E. coli. Oligonucleotides were customsynthesized and purified by Microsynth (Balgach, Switzerland) as follows. 
All mutants were expressed by using the same procedure as before. After sonication in lysis buffer (20 mM Tris⅐HCl, pH 8.0͞10 mM imidazole͞300 mM NaCl), the supernatant was applied to a metal-chelate affinity column (Ni 2ϩ -NTA; Qiagen) and washed with lysis buffer containing 40 mM imidazole. Fab mutants were eluted with a buffer containing 20 mM Tris, pH 8.0, 300 mM NaCl, and 250 mM imidazole and were dialyzed afterward against PBS (pH 7.4).
Catalytic Activity Assay. Catalytic reactions were carried out by mixing 0.6 l of a 10 mM stock solution of substrate 2 in a 1:1 acetonitrile͞water solution ( Fig. 1 ) with 19.2 l of protein solutions at a concentration of 0.5 mg͞ml in PBS (pH 7.4) at 22°C (300 M final concentration). An identically prepared solution with 0.2 l of 5 mM inhibitor 1a (50 M final concentration) was used to check specific inhibition. All reactions were monitored by HPLC. The substrate and product were separated on an analytical RP-C18 column (218TP54, 22 cm ϫ 0.45 cm, 300-Å pore size; Vydac, Hesperia, CA) after a 30-min incubation. Retention times (t R ) were as follows (eluent, 1.5 ml/min; H 2 O/acetonitrile ϭ 75:25; detection by UV at 230 nm): t R (ketone 3) ϭ 3.3 min, t R (substrate 2) ϭ 15.7 min. The percentage conversion indicating the catalytic activity was calculated from peak integration. All percentages shown in Table 2 refer to the hexa-His-tagged chimeric Fab 14D9 wild type. Enantioselectivity Assay. Substrate 2 was incubated with the antibody samples as described above on a 200-l scale. The reaction mixture was separated by RP-C18-HPLC, and the peak of ketone 3 was collected, lyophilized, redissolved in 1:1 hexane͞ isopropanol solution, and analyzed on a 22 cm ϫ 0.45 cm chiral-phase column (Chiralpak OD; Daicel Chemical Industries, Osaka) with a 7:3 hexane͞isopropanol eluent at 1 ml͞min {t R [(R)-ketone 3] ϭ 8.6 min, t R [(S)-ketone 3] ϭ 12.4 min} (14) . The absolute configuration of the products has been established earlier by chemical correlation (22) .
Crystallization. All crystallization experiments were performed by using the vapor diffusion method at 20°C. The crystals of the chimeric Fab fragment 14D9 were grown by using the sitting- drop procedure with reservoirs containing 80 l of 8% polyethylene glycol 3350͞50 mM citric acid, pH 3.0. Drops were set up by mixing 2 l of a protein solution (20 mg͞ml Fab in 5 mM NaCl) with 1 l of the reservoir solution. The purified chimeric Fab 19C9 could be cocrystallized with its hapten 1a by using the hanging-drop procedure and wells containing 500 l of 45% (vol͞vol) 2-methyl-2,4-pentanediol, 0.2 M mono ammonium dihydrogen phosphate, and 0.1 M Tris⅐HCl (final pH 8.5). Three microliters of a protein solution (16 mg/ml Fab in 5 mM NaCl͞0.6 mM hapten 1a) was mixed with 2 l of the well solution. An additional 0.5 l of 1 M NaI was added to the drop only to modify the crystal growth.
X-Ray Data Collection and Structure Determination. Crystals of chimeric Fab 14D9 were f lash-cooled to 110 K by using 30% PEG 400 as cryoprotectant. For the 19C9 -hapten 1a (19C9 -1a) complex, the crystallization buffer was used as cryoprotectant directly. Data were processed with MOSFLM 6.0 and SCALA of the CCP4 program suite (23 . This pocket is open and exposes half of the hapten 1a to the solvent (Fig. 2) . The ethanolamide side chain of hapten 1a is immobilized by two hydrogen bonds, one between the terminal OH group and the main-chain nitrogen of Asp H52 and another between the carboxamide oxygen atom and the side-chain N atom of Trp H47 . The hapten's aromatic group interacts with Phe H98 . Ligand recognition also involves multiple van der Waals contacts and a weak electrostatic interaction between the hapten's ammonium group and Asp H101 , which will be shown to be the critical catalytic carboxyl group (see below).
The structure of Fab 14D9 apo form is almost superimposable with that of Fab 19C9, which is not surprising given their high degree of sequence identity (light chain, 92.7%; heavy chain, 92.4%) (Fig. 3) Proton Transfer Mechanism. The recombinant humanized Fab 14D9 and Fab 19C9 catalyze the enantioselective protonation of enol ether 2 to form ketone (S)-3 with high enantioselectivity (Ͼ95% ee), with antibody 19C9 being Ϸ20-fold less active than 14D9, in agreement with the catalytic activities of the parent hybridoma-derived immunoglobulins (27) . A possible role of Asp H101 in catalysis is suggested by the spatial proximity of this group to the hapten's ammonium cation. This hypothesis was confirmed by mutating each of the three acidic residues found within the complementarity-determining region regions to Ala or Asn. Ala replacements at position H31 and H52 resulted in a 10% and 30% reduction in catalytic activity. By contrast, there was a complete loss of catalysis in the Asp The chemical reaction mechanism for the hydrolysis of enol ether 2 is well established (28) . The rate-limiting step is the initial general-acid-catalyzed proton transfer from a catalytic acid to the ␤-carbon of the enol ether to form intermediate 4, which is trapped by water to give hemiacetal 5. The hemiacetal is unstable and collapses to the carbonyl reaction product and methanol. Kinetic studies with antibody 14D9 suggest that the antibodycatalyzed reaction follows the same mechanism, with the stereogenerating protonation step being catalyzed by an ionizable residue of pK a ϭ 4.5.
To gain a structural insight into the reaction mechanism, we placed enol ether 2 in the antibody-binding pocket by overlaying its aromatic benzamide side chain with that of hapten 1a as observed in the 19C9-1a complex (Fig. 4) . This arrangement is supported by earlier structure-activity relationship data measured with 11 different reactive substrates and 23 inhibitory hapten analogs (27, 28) . Despite steric crowding, especially between the methoxycyclopentene group and Phe H98 , the substrate could be arranged with its reactive double bond pointing toward the catalytic residue Asp H101 . The position of the aromatic ring of Phe H98 is ill defined in two of the three crystallographically independent molecules, indicating a high degree of flexibility. Hence, it is reasonable to assume that it could adopt the conformation observed in the 19C9 complex, avoiding steric clashes.
The distance between the enol ether's ␤-carbon and the carboxyl group is too long (Ϸ4.4 Å) to be compatible with direct proton transfer from that group and suggests that a water molecule transiently hydrogen-bonded to Asp H101 might serve as a relay. This water molecule would also be optimally placed to trap the intermediate carbocation 4 to form hemiacetal 5, resulting in an overall syn-addition of water to the enol ether double bond (Fig. 5) . Indeed, water molecule W89, which was found in the 19C9 complex structure and is hydrogenbonded to the phenol group of Tyr L55 and the main-chain carbonyl oxygens of residues H100 and H100C, is located in a position that is favorable for the attack of the protonated carbocation. On the other hand, its position is not particularly suitable to transfer a proton to the ␤-carbon of the reactive double bond. In a docking study, hemiacetal 5 is readily placed in the binding pocket with its hydroxyl group interacting in hydrogen-bonding fashion with Asp H101 and being close to water W89 (Fig. 6) . The critical role of Tyr L36 was evidenced by the fact that the Tyr
L36
Phe mutant was catalytically inactive, whereas the structurally similar Tyr
H35
Phe mutant retained 30% of catalytic power and a high enantioselectivity as the wild type. Remarkably, the Asp H101 Glu and Asp
H101
His mutants retained good catalytic activity with unaltered enantioselectivity. In these mutants, a direct proton transfer from the catalytic group at position H101 probably takes place with subsequent addition of a water molecule from the solvent, resulting in an overall trans-addition of water.
Origin of the Enantioselectivity. The enantioselectivity of the protonation reaction is explained by the fact that enol ether 2 can only be placed within the binding pocket with the Si-face of enol ether pointing toward the catalytic residues. In this conformation, the methoxy group is in hydrogen-bonding distance to the side-chain of Gln L89 , which is very important for catalysis as shown by mutagenesis ( Table 2 ). The confor- 
Conclusion
The structural and mutagenesis experiments above demonstrate the molecular mechanism of the 14D9-catalyzed enantioselective protonation reaction. The role played by the hydrogen-bonding network surrounding the catalytic residue Asp H101 , in particular the control of activity by the ''noncatalytic'' residues Tyr L36 and Thr L46 , is remarkable. These observations disprove the notion that catalytic antibodies are mere binding pockets equipped with a single catalytic residue, and they illustrate the necessity for subtle interactions to obtain catalytic activity. It must be pointed out that most of the interactions leading to catalysis were not designed. Indeed the immunogenic hapten 1 merely ensured the selection of antibodies capable of binding the substrates at the aromatic benzamide group and possessing a binding pocket for the reactive functional group favoring the formation of a positive charge. Whether the occurrence of catalysis was purely serendipitous or whether it was made possible by a natural tendency of antibodies to acquire catalytic activity remains an open question. Additional modeling experiments should rationalize (on the basis of the present crystal structure) other hydrolytic reactions that are related to the hydrolysis of enol ether 2 and are also catalyzed, albeit more weakly, by antibody 14D9 (31-35). *The activity was determined by hydrolysis of enol ether 3 and monitored with RP-HPLC. † The purified product of ketone 5 was analyzed by employing an achiral HPLC system, and the enantioselectivity was calculated from the peak areas of each enantiomer of ketone 5. 
